Trials / Conditions / Oropharyngeal Carcinoma

Oropharyngeal Carcinoma

20 registered clinical trials studyying Oropharyngeal Carcinoma — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs NCT07418034	University of Maryland, Baltimore	Phase 2
Not Yet Recruiting	SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer NCT07241273	UNICANCER	N/A
Not Yet Recruiting	Transmission of Oncogenic HPV Infection Among Families NCT07036211	Tampere University Hospital	—
Recruiting	A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer NCT06984861	Memorial Sloan Kettering Cancer Center	Phase 2
Recruiting	Thermoradiotherapy for Locally Advanced Head and Neck Cancer Patients NCT06761937	Erasmus Medical Center	Phase 1
Active Not Recruiting	Can Recurrence of Cancer in the Oropharynx be Detected by Blood Samples? NCT06592716	Rigshospitalet, Denmark	—
Recruiting	Multidimensional and Multimodal Profiling of Oropharyngeal Carcinoma NCT05880797	Stanford University	—
Recruiting	A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Canc NCT05491512	Memorial Sloan Kettering Cancer Center	Phase 2
Active Not Recruiting	Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT NCT05075980	Mayo Clinic	Phase 2
Completed	Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer NCT04788264	Thomas Jefferson University	N/A
Active Not Recruiting	Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharynge NCT04874493	M.D. Anderson Cancer Center	—
Unknown	Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCC NCT04867330	Fudan University	N/A
Active Not Recruiting	High Dose Steroid Therapy (Prednisone or Methylprednisolone) for the Improvement of Symptoms of Late Radiation NCT04151082	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Unknown	De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations NCT04012502	Fudan University	N/A
Terminated	Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck Canc NCT03809624	Inhibrx Biosciences, Inc	Phase 1
Recruiting	Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma NCT03215719	NYU Langone Health	Phase 2
Unknown	Anti-EGFR Therapy With IMRT Concurrent Chemoradiotherapy in Locally Advanced OPC Resistant to Induction Chemot NCT04508829	Fudan University	Phase 2
Completed	Multispectral Imaging to Characterize Patterns of Vascular Supply Within Lymphoepithelial Mucosa in Oropharyng NCT02365844	Stanford University	—
Completed	Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer NCT01440270	Shanghai Jiao Tong University School of Medicine	Phase 2
Completed	Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer NCT01434394	Shanghai Jiao Tong University School of Medicine	Phase 2 / Phase 3